{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:04:33Z","timestamp":1784819073321,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bbrc.2022.04.086","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:04:58Z","timestamp":1650625498000},"page":"190-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Crystal structure of SARS-CoV 3C-like protease with baicalein"],"prefix":"10.1016","volume":"611","author":[{"given":"Jingwen","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.04.086_bib1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Stanley","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2022.04.086_bib2","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2022.04.086_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1408.002","article-title":"The molecular biology of SARS coronavirus","volume":"1102","author":"Namita","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2022.04.086_bib4","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2022.04.086_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mjafi.2020.04.008","article-title":"SARS-CoV-2SARS-CoV-2: camazotz's curse","volume":"76","author":"Anand","year":"2020","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.bbrc.2022.04.086_bib6","article-title":"A\u00a0TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic","author":"Tirosh","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.04.086_bib7","first-page":"368","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.04.086_bib8","article-title":"Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble","volume":"433","author":"Akinori","year":"2021","journal-title":"Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.04.086_bib9","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by dalcetrapib","volume":"6","author":"Niesor Eric","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2022.04.086_bib10","doi-asserted-by":"crossref","unstructured":"Zhenming Jin, Yao Zhao, Yuan Sun et\u00a0al Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur, Nat. Struct. Mol. Biol. 27, 529\u2013532. https:\/\/pubmed.ncbi.nlm.nih.gov\/32382072.","DOI":"10.1038\/s41594-020-0440-6"},{"key":"10.1016\/j.bbrc.2022.04.086_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.04.086_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11427-020-1791-3","article-title":"Structure of SARS-CoV-2 main protease in the apo state","volume":"64","author":"Zhou","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bbrc.2022.04.086_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.12.005","article-title":"Potential SARS-CoV-2 main protease inhibitors","author":"Banerjee","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2022.04.086_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.scib.2020.10.018","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode","volume":"66","author":"Jian","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.bbrc.2022.04.086_bib15","article-title":"Structure-Based discovery and structural basis of a novel broad-spectrum natural product against the main protease of coronavirus","volume":"96","author":"Zhang","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2022.04.086_bib16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2174\/0929867327666200713184138","article-title":"Recent research on flavonoids and their biomedical applications","volume":"28","author":"Wen","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2022.04.086_bib17","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","author":"Jo","year":"2020","journal-title":"Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2022.04.086_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10529-011-0845-8","article-title":"Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris","volume":"34","author":"Nguyen","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.bbrc.2022.04.086_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in\u00a0vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2022.04.086_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114538","article-title":"Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method","volume":"209","author":"Zhu","year":"2022","journal-title":"Pharm. Biomed. Anal."},{"key":"10.1016\/j.bbrc.2022.04.086_bib21","doi-asserted-by":"crossref","DOI":"10.1107\/S2053230X21009523","article-title":"Crystal structures of human coronavirus NL63 main protease at different pH values","author":"Gao","year":"2021","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.bbrc.2022.04.086_bib22","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams Paul","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bbrc.2022.04.086_bib23","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Paul","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bbrc.2022.04.086_bib24","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.04.086_bib25","first-page":"1","article-title":"Targeting two potential sites of SARS-CoV-2 main protease through computational drug repurposing","author":"Prakash","year":"2022","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2022.04.086_bib26","article-title":"Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2","volume":"119","author":"Zhao","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2022.04.086_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jmb.2006.11.073","article-title":"Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction","volume":"366","author":"Xue","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.04.086_bib28","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1021\/acs.jproteome.0c00683","article-title":"Theoretical insights into the anti-SARS-CoV-2 activity of chloroquine and its analogs and in silico screening of main protease inhibitors","volume":"19","author":"Achutha","year":"2020","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.bbrc.2022.04.086_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.04.086_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb7269","article-title":"A\u00a0highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.04.086_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Alimuddin","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2022.04.086_bib32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/D0SC04942E","article-title":"Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease","volume":"12","author":"Anna","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbrc.2022.04.086_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.04.086_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.csbj.2022.03.009","article-title":"Inhibition of the main protease of SARS-CoV-2 (M) by repurposing\/designing drug-like substances and utilizing nature's toolbox of bioactive compounds","volume":"20","author":"Io","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbrc.2022.04.086_bib35","first-page":"1","article-title":"Trilogy of COVID-19: infection, vaccination, and immunosuppression","author":"Dinesh","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.bbrc.2022.04.086_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112711","article-title":"The development of Coronavirus 3C-Like protease (3CL) inhibitors from 2010 to 2020","volume":"206","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2022.04.086_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14756366.2020.1801672","article-title":"Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro","volume":"35","author":"Jo","year":"2020","journal-title":"Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2022.04.086_bib38","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbrc.2005.02.061","article-title":"The substrate specificity of SARS coronavirus 3C-like proteinase","volume":"329","author":"Fan","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22006222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22006222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:19:09Z","timestamp":1757765949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22006222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S0006291X22006222"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.086","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystal structure of SARS-CoV 3C-like protease with baicalein","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}